Whiting John Kimball IV Buys Shares of TGEN
TGEN's General Counsel, Whiting John Kimball IV, recently bought 19,342 shares.
Key Points
- Whiting John Kimball IV, TGEN's General Counsel, acquired 19,342 shares on June 26, 2026.
- Shares of TGEN traded at $5.22 on Wednesday, with several institutional investors adjusting their positions.
- Analysts from Roth Capital and H.C. Wainwright maintain buy ratings, with targets of $15.00 and $4.50 respectively.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Whiting John Kimball IV, General Counsel & Secretary at TGEN, bought 19,342 shares on June 26, 2026. This insider transaction was not part of a pre-planned trading program, indicating personal decision-making in the purchase.
Other Institutional Activity in TGEN
Vanguard Capital Management LLC opened a new position in TGEN, acquiring 769,964 shares valued at approximately $1.97 million. Bard Associates Inc slightly reduced its stake by 798 shares, now holding 688,309 shares worth about $1.76 million, reflecting a 0.1% decrease. Clear Harbor Asset Management, LLC increased its holdings by 40,000 shares to a total of 650,000 shares, valued at $1.66 million, a 6.6% increase. Portolan Capital Management, LLC trimmed its position by 2,255 shares, holding 443,555 shares worth about $1.14 million, marking a 0.5% decrease.
Tecogen Inc. Stock Up 70.6%
Shares of TGEN traded near $5.22 on Wednesday. The stock has seen a 52-week range from a low of $3.50 to a high of $7.80. Its 50-day moving average is $5.10, and the 200-day moving average is $5.30, indicating some stability in recent months.
$TGEN stock price
Daily closing prices, year to date. Not investment advice.
Insider Buying and Selling at Tecogen Inc.
On June 26, 2026, several insiders at TGEN made purchases. Angelina Galiteva bought 25,000 shares at $5.17 each. CEO Abinand Rangesh acquired a total of 200,122 shares, with 26,041 shares at $5.17 and the rest unspecified in price. Roger Deschenes, CAO, and Stephen Lafaille, VP of Business Development, each bought 29,013 shares. COO and President Robert Panora purchased 9,671 shares.
Analysts Set New Price Targets
On August 18, 2025, Roth Capital initiated coverage of TGEN with a 'buy' rating and a price target of $15.00. H.C. Wainwright reiterated its 'buy' rating on March 17, 2023, with a price target of $4.50. The consensus among analysts suggests a positive outlook for TGEN.
Bottom Line
Insider buying activity at TGEN, particularly by General Counsel Whiting John Kimball IV, signals confidence in the company's prospects. Institutional investors have adjusted their holdings, with some increasing their stakes. Analysts maintain positive ratings, suggesting potential growth. Remember, insider transactions and institutional filings are often backward-looking and may not reflect current positions.
Get Tecogen Inc. alerts
New 13F filings, insider trades, and analyst moves on $TGEN, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.